Biogen, Inc. (BIIB)
Biogen Market Cap : 28.73B for Feb. 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 983.97B |
| Merck & Co., Inc. | 308.52B |
| AbbVie, Inc. | 403.79B |
| Pfizer Inc. | 154.14B |
| Stoke Therapeutics, Inc. | 2.036B |
Market Cap Related Metrics
| PE Ratio | 22.23 |
| PS Ratio | 3.014 |
| Price to Book Value | 1.574 |
| Price to Free Cash Flow | 14.59 |
| Price | 195.79 |
| Earnings Yield | 4.50% |
| Operating PE Ratio | 11.87 |
| Normalized PE Ratio | 16.79 |